Inhibitory effects of the essential oil from SuHeXiang Wan on the central nervous system after inhalation

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 4, 2004, Pages 515-519

  Koo, Byung Soo ^a   Lee, Seung Il ^b   Ha, Jeoung Hee ^c   Lee, Dong Ung ^d  

^a Department of Internal Medicine   (South Korea)

^b Sorabol College   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

Anticonvulsive effect; Aroma therapy; Essential oil; GABAergic neuromodulation; Sedative effect; SuHeXiang Wan

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; ESSENTIAL OIL; FLUMAZENIL; FLUNITRAZEPAM; FRAGRANCE; GLUTAMIC ACID; HERBACEOUS AGENT; LIPID; PENTETRAZOLE; PENTOBARBITAL; PICROTOXIN; SODIUM CHLORIDE; STRYCHNINE; SUHEXIANG WAN; TRITIUM; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CONVULSION; DRUG RECEPTOR BINDING; ENZYME INHIBITION; EPILEPSY; GABAERGIC TRANSMISSION; LIPID PEROXIDATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PROTEIN CONTENT; SLEEP TIME; STATISTICAL SIGNIFICANCE; ANIMAL; BRAIN LEVEL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYTOTHERAPY; SEIZURE; SLEEP;

4-AMINOBUTYRATE TRANSAMINASE; ADMINISTRATION, INHALATION; ANIMALS; ANTICONVULSANTS; ANTIOXIDANTS; BRAIN; BRAIN CHEMISTRY; DRUGS, CHINESE HERBAL; GLUTAMIC ACID; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED ICR; OILS, VOLATILE; PENTYLENETETRAZOLE; PHYTOTHERAPY; PICROTOXIN; RECEPTORS, GABA-A; SEIZURES; SLEEP; STRYCHNINE;

EID: 16544381346     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.515     Document Type: Article

References (17)

1. Bensky D., Gamble A., "Chinese Herbal Medicine (Materia Medica)," Eastland Press, Seattle, 1986, p. 592.
2. Ma X. Z., Yu X. B., Chen J. J., Liang Z. M., Coa T. C., Wang Y., Pharmaceutica Sinica, 28, 537-542 (1993).
3. Buchbauer G., Jirovetz L., Jaeger W., Plank C., Dietrich H., J. Pharm. Sci., 82, 660-664 (1993).
4. Jaeger W., Buchbauer G., Jirovetz L., Dietrich H., Plank C., J. Essential Oil Res., 4, 387-394 (1992).
5. Buchbauer G., Jirovetz L., Jager W., Dietrich H., Plank C., Z. Naturforsch. C, 46, 1067-1072 (1991).
6. Buchbauer G., Jaeger W., Jirovetz L., Meyer F., Dietrich H., Pharmazie, 47, 620-622 (1992).
7. Kovar K. A., Gropper B., Friess D., Ammon H. P. T., Planta Med., 53, 315-318 (1987).
8. Koo B. S., Park K. S., Ha J. H., Park J. H., Lim J. C., Lee D. U., Biol. Pharm. Bull., 26, 978-982 (2003).
9. Ha J. H., Shin S. M., Lee S. K., Kim J. S., Shin U. S., Huh K., Kim J. A., Yong C. S., Lee N. J., Lee D. U., Planta Med., 67, 877-880 (2001).
10. Allen I. C., Griffthis R., J. Chromatogr., 336, 385-391 (1984).
11. Ohkawa H., Ohishi N., Yagi K., Anal. Biochem., 95, 351-358 (1979).
12. Metcalf B. W., Biochem. Pharmacol., 28, 1705-1712 (1979).
13. Basile A. S., Jones E. A., Skolnick P., Pharmacol. Rev., 43, 27-71 (1991).
14. Drugan R. C., Basile A. S., Ha J. H., Ferland R. J., Brain Res., 661, 127-136 (1994).
15. Ha J. H., Pannell L., Drugan R. C., Ferland R., Basile A. S., "Neuroscience Protocols," Elsevier Sciences, U.S.A., 1996, pp. 1-12.
16. Gilman S. C., Bonner M. J., Pellmar T. C., Free Radic. Biol. Med., 15, 671-675 (1993).
17. Liu J., Mori A., Neuropharmacology, 31, 1287-1298 (1992).